Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

Japan’s Nippon Steel has completed its purchase of U.S. Steel after reaching a national-security agreement with the White ...

Bambu Ventures plans to bid $10 million for 23andMe’s online health-care platform as the DNA testing firm seeks court approval to sell its assets to its cofounder and a nonprofit.

The National Weather Service issued the heat advisory earlier this week, with temperatures in central Alaska climbing to the ...

The Wojcicki sisters were raised in a quiet Silicon Valley suburb by their mother, Esther Wojcicki, a renowned educator and ...

Anne Wojcicki, co-founder and former CEO of 23andMe, will regain control of the embattled genetic testing company through a ...

TTAM Research Institute, led by Anne Wojcicki, to acquire nearly all of 23andMe’s assets for $305 million. The deal tops a previous $256 million offer from Regeneron Pharmaceuticals.

Westlake and Ascend close plants, Chemify opens AI-robotics lab, Formation licenses gusacitinib to Sanofi, and more ...

23andMe founder Anne Wojcicki is hoping to make a fresh bid for the genetic testing firm, riding out a takeover deal with Regeneron ... Update: Rumour confirmed as Lilly buys Verve Therapeutics.

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...

Twenty-seven states and the District of Columbia have filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The Monday ...